中国心血管病研究2024,Vol.22Issue(8) :678-683.DOI:10.3969/j.issn.1672-5301.2024.08.002

冠心病合并糖尿病患者介入治疗的研究进展

Research progress in percutaneous coronary interventional treatment for patients with coronary heart disease and diabetes mellitus

何雪荣 武刚
中国心血管病研究2024,Vol.22Issue(8) :678-683.DOI:10.3969/j.issn.1672-5301.2024.08.002

冠心病合并糖尿病患者介入治疗的研究进展

Research progress in percutaneous coronary interventional treatment for patients with coronary heart disease and diabetes mellitus

何雪荣 1武刚2
扫码查看

作者信息

  • 1. 830000 新疆维吾尔自治区乌鲁木齐市,新疆医科大学第四临床医学院
  • 2. 新疆维吾尔自治区中医医院心内二科
  • 折叠

摘要

冠心病合并糖尿病患者是一个不断增长的人群.糖尿病患者的冠状动脉病变复杂并且行经皮冠状动脉介入治疗的预后较差.因此,介入器械的改进和抉择对糖尿病患者来说尤为重要.随着介入治疗的发展和相关研究开展,新一代的药物洗脱支架、生物可吸收支架和药物涂层球囊的应用可能会为接受经皮冠状动脉介入治疗的糖尿病患者提供潜在优势.现对近期冠心病合并糖尿病患者介入治疗的研究进行总结,以期对临床实践提供借鉴.

Abstract

The patients with coronary heart disease and diabetes mellitus are a growing population.The patients often have complex coronary artery disease and poor prognosis of percutaneous coronary intervention.Therefore,the improvement and selection of interventional devices are particularly important for th patients.With the development of interventional therapy and the implementation of the related research,the clinical application of a new generation of drug-eluting stents,bioabsorbable scaffold,and drug coated balloons may provide more benefits for the patients undergoing percutaneous coronary intervention.This paper summarizes the recent researchs on interventional treatment of the patients with coronary heart disease and diabetes mellitus in order to provide reference for clinical practice.

关键词

冠心病/糖尿病/经皮冠状动脉介入治疗/药物洗脱支架/生物可吸收支架/药物涂层球囊

Key words

Coronary heart disease/Diabetes mellitus/Percutaneous coronary intervention/Drug-eluting stents/Bioabsorbable scaffold/Drug coated balloon

引用本文复制引用

基金项目

新疆维吾尔自治区自然科学基金(2021D01C221)

出版年

2024
中国心血管病研究
中国医师协会,煤炭总医院

中国心血管病研究

CSTPCD
影响因子:0.878
ISSN:1672-5301
参考文献量5
段落导航相关论文